Immunogenicity risk assessment of synthetic peptide drugs and their impurities

by Elena Iemma | Jul 27, 2023

Immunogenicity risk assessment of synthetic peptide drugs and their impurities – ScienceDirect

In silico immunogenicity assessment for sequences containing unnatural amino acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements

by Elena Iemma | Oct 11, 2022

Poster: Innovative preclinical assessment tools for safety and efficacy of protein and peptide therapeutics… Of Peptides and P-ANDAS

by Elena Iemma | Sep 22, 2022

Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics… of Peptides and P-ANDAS

The iVAX Toolkit: An in silico platform for epitope discovery with applications to human and animal vaccine design

by Annie De Groot | Oct 23, 2019

EpiVax_ISV_iVAX_23Oct19

Designing a Better Assay – HLA-DR Binding Assays as a Tool for Immunogenicity Screening: Developing the Best Practices for Determining Immunogenicity

by Annie De Groot | Oct 9, 2018

EpiVax_AAPS HLA-binding poster epivax format[1]